Susceptibility of Diverse HIV-1 Patient Isolates to the Maturation Inhibitor, Bevirimat (MPC-4326*), is Determined by Clade- Specific Polymorphisms in Gag CA-SP1
Journal article published in 2009 by
K. Salzwedel,
F. Hamy,
S. Louvel,
M. Sakalian,
M. Reddick,
C. Finnegan,
D. Martin,
S. Mccallister,
T. Klimkait,
G. Allaway
